Sep 22, 2026 11 0
Uploaded by Aria Callaghan
Favorite
Share
More Options
13
Nivolumab for unresectable cutaneous epithelial malignancies - an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1)_Page 1

Open in WPS to view all 13 pages